Stein Sæbøe-Larsen

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The most effective anticancer immune responses are probably directed against patient-specific neoantigens. We have developed a melanoma vaccine targeting this individual mutanome based on dendritic cells (DCs) loaded with autologous tumor-mRNA. Here, we report a phase I/II trial evaluating toxicity, immune response and clinical outcome in 31 metastatic(More)
  • 1